2% dorzolamide and cornea: an ultrabiomicroscopic study.
Uva
M G
MG
Institute of Ophthalmology, University of Catania.
Russo
V
V
Longo
A
A
Ott
J P
JP
Reibaldi
A
A
D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D002452:Cell Count; D003315:Cornea / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D004728:Endothelium, Corneal / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008875:Middle Aged; D009883:Ophthalmic Solutions; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use; D013876:Thiophenes / Q000008:administration & dosage* / Q000627:therapeutic use; D014463:Ultrasonography; D014792:Visual Acuity
D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide